Bevacizumab, a monoclonal antibody against VEGF-A used in the treatment for solid cancers, has also been shown to be effective in treating psoriasis, including one case of complete remission for a patient being treated for metastatic colon cancer (81). Here, VEGFA is linked to psoriasis.